Steven F. Dowdy

23.7k total citations · 9 hit papers
123 papers, 18.6k citations indexed

About

Steven F. Dowdy is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Steven F. Dowdy has authored 123 papers receiving a total of 18.6k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Molecular Biology, 34 papers in Oncology and 31 papers in Genetics. Recurrent topics in Steven F. Dowdy's work include RNA Interference and Gene Delivery (57 papers), Advanced biosensing and bioanalysis techniques (32 papers) and Virus-based gene therapy research (27 papers). Steven F. Dowdy is often cited by papers focused on RNA Interference and Gene Delivery (57 papers), Advanced biosensing and bioanalysis techniques (32 papers) and Virus-based gene therapy research (27 papers). Steven F. Dowdy collaborates with scholars based in United States, Sweden and Germany. Steven F. Dowdy's co-authors include Jehangir S. Wadia, Steven R. Schwarze, Alan L. Ho, Radu V. Stan, Michelle Becker‐Hapak, Eric L. Snyder, James M. Roberts, Bryan R. Meade, Arnaud Besson and Aaron D. Springer and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Steven F. Dowdy

121 papers receiving 18.2k citations

Hit Papers

In Vivo Protein Transduction: Delivery of a Biologically ... 1993 2026 2004 2015 1999 2004 2008 2017 1998 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
    1999 2.1k citations Alan L. Ho, Steven F. Dowdy et al. profile →
  2. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis
    2004 1.3k citations Jehangir S. Wadia, Steven F. Dowdy et al. profile →
  3. CDK Inhibitors: Cell Cycle Regulators and Beyond
    2008 883 citations Steven F. Dowdy et al. profile →
  4. Overcoming cellular barriers for RNA therapeutics
    2017 876 citations Steven F. Dowdy profile →
  5. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration
    1998 819 citations Hikaru Nagahara, Eric L. Snyder et al. profile →
  6. Physical interaction of the retinoblastoma protein with human D cyclins
    1993 666 citations Steven F. Dowdy et al. profile →
  7. Cationic TAT peptide transduction domain enters cells by macropinocytosis
    2004 560 citations Jehangir S. Wadia, Steven F. Dowdy et al. profile →
  8. GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics
    2018 509 citations Steven F. Dowdy et al. Nucleic Acid Therapeutics profile →
  9. Reversing a model of Parkinson’s disease with in situ converted nigral neurons
    2020 344 citations Hao Qian, Xinjiang Kang et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven F. Dowdy United States 62 15.1k 3.7k 3.4k 1.9k 1.6k 123 18.6k
Paul A. Khavari United States 68 12.2k 0.8× 2.4k 0.6× 1.8k 0.5× 2.0k 1.0× 4.2k 2.5× 151 16.9k
David W. Speicher United States 72 12.6k 0.8× 2.3k 0.6× 1.2k 0.3× 2.0k 1.0× 1.4k 0.9× 278 19.3k
Hartmut Beug Austria 82 16.1k 1.1× 7.4k 2.0× 4.2k 1.3× 3.4k 1.8× 3.4k 2.1× 254 25.3k
Victor Koteliansky United States 57 10.3k 0.7× 1.8k 0.5× 1.2k 0.4× 3.0k 1.6× 2.2k 1.3× 125 17.2k
Corazon D. Bucana United States 66 8.2k 0.5× 4.6k 1.2× 784 0.2× 2.0k 1.0× 3.6k 2.2× 145 13.9k
G. Yancey Gillespie United States 63 7.6k 0.5× 5.1k 1.4× 4.9k 1.5× 2.5k 1.3× 2.3k 1.4× 282 15.0k
Peter F. Johnson United States 64 11.2k 0.7× 2.4k 0.7× 2.6k 0.8× 3.4k 1.8× 1.8k 1.1× 127 17.0k
Carl Blobel United States 72 8.0k 0.5× 5.6k 1.5× 1.0k 0.3× 2.8k 1.4× 2.7k 1.6× 148 16.2k
Hanswalter Zentgraf Germany 68 7.9k 0.5× 2.0k 0.5× 2.8k 0.8× 1.4k 0.7× 1.0k 0.6× 226 14.1k
Jer‐Tsong Hsieh United States 63 7.5k 0.5× 3.4k 0.9× 2.0k 0.6× 897 0.5× 2.3k 1.4× 267 12.9k

Countries citing papers authored by Steven F. Dowdy

Since Specialization
Citations

This map shows the geographic impact of Steven F. Dowdy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven F. Dowdy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven F. Dowdy more than expected).

Fields of papers citing papers by Steven F. Dowdy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven F. Dowdy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven F. Dowdy. The network helps show where Steven F. Dowdy may publish in the future.

Co-authorship network of co-authors of Steven F. Dowdy

This figure shows the co-authorship network connecting the top 25 collaborators of Steven F. Dowdy. A scholar is included among the top collaborators of Steven F. Dowdy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven F. Dowdy. Steven F. Dowdy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dowdy, Steven F., et al.. (2024). Stereopure ASOs: An unanticipated increase in selectivity for targeting mutant HTT. Molecular Therapy — Nucleic Acids. 35(3). 102312–102312. 1 indexed citations
2.
Dowdy, Steven F.. (2023). Endosomal escape of RNA therapeutics: How do we solve this rate-limiting problem?. RNA. 29(4). 396–401. 75 indexed citations
3.
Kaulich, Manuel, Verena M. Link, John D. Lapek, et al.. (2021). A Cdk4/6-dependent phosphorylation gradient regulates the early to late G1 phase transition. Scientific Reports. 11(1). 14736–14736. 11 indexed citations
4.
Palm‐Apergi, Caroline & Steven F. Dowdy. (2021). Protein Delivery by PTDs/CPPs. Methods in molecular biology. 2383. 257–264. 4 indexed citations
5.
Thompson, Matthew A., et al.. (2020). The TAT Protein Transduction Domain as an Intra-Articular Drug Delivery Technology. Cartilage. 13(2_suppl). 1637S–1645S. 5 indexed citations
6.
Qian, Hao, Xinjiang Kang, Jing Hu, et al.. (2020). Reversing a model of Parkinson’s disease with in situ converted nigral neurons. Nature. 582(7813). 550–556. 344 indexed citations breakdown →
7.
Hagopian, Jonathan C., Alexander Hamil, Arjen van den Berg, et al.. (2017). Induction of RNAi Responses by Short Left-Handed Hairpin RNAi Triggers. Nucleic Acid Therapeutics. 27(5). 260–271. 4 indexed citations
8.
Tobias, Irene S., Manuel Kaulich, Peter K. Kim, et al.. (2015). Protein kinase Cζ exhibits constitutive phosphorylation and phosphatidylinositol-3,4,5-triphosphate-independent regulation. Biochemical Journal. 473(4). 509–523. 27 indexed citations
9.
Kogiso, Tomomi, Hikaru Nagahara, Motoyuki Otsuka, Keiko Shiratori, & Steven F. Dowdy. (2013). Transdifferentiation of human fibroblasts into hepatocyte-like cells by defined transcriptional factors. Hepatology International. 7(3). 937–944. 22 indexed citations
10.
Cerchietti, Leandro, José M. Polo, Gustavo Felippe da Silva, et al.. (2008). Sequential Transcription Factor Targeting for Diffuse Large B-Cell Lymphomas. Cancer Research. 68(9). 3361–3369. 25 indexed citations
11.
Meade, Bryan R. & Steven F. Dowdy. (2007). Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides. Advanced Drug Delivery Reviews. 60(4-5). 530–536. 148 indexed citations
12.
Cai, Shi-Rong, Guang Xu, Michelle Becker‐Hapak, et al.. (2006). The kinetics and tissue distribution of protein transduction in mice. European Journal of Pharmaceutical Sciences. 27(4). 311–319. 85 indexed citations
13.
Havens, Courtney G., Alan L. Ho, Naohisa Yoshioka, & Steven F. Dowdy. (2006). Regulation of Late G1/S Phase Transition and APCCdh1by Reactive Oxygen Species. Molecular and Cellular Biology. 26(12). 4701–4711. 153 indexed citations
14.
Snyder, Eric L. & Steven F. Dowdy. (2005). Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids invivo. Expert Opinion on Drug Delivery. 2(1). 43–51. 78 indexed citations
15.
Tanaka, Yoshiyuki, Steven F. Dowdy, David C. Linehan, Timothy J. Eberlein, & Peter S. Goedegebuure. (2003). Induction of Antigen-Specific CTL by Recombinant HIV Trans -Activating Fusion Protein-Pulsed Human Monocyte-Derived Dendritic Cells. The Journal of Immunology. 170(3). 1291–1298. 31 indexed citations
16.
Denicourt, Catherine & Steven F. Dowdy. (2003). Protein transduction technology offers novel therapeutic approach for brain ischemia. Trends in Pharmacological Sciences. 24(5). 216–218. 44 indexed citations
17.
McAllister, Sandra S., Michelle Becker‐Hapak, Giuseppe Pintucci, Michele Pagano, & Steven F. Dowdy. (2002). Novel p27 kip1 C-Terminal Scatter Domain Mediates Rac-Dependent Cell Migration Independent of Cell Cycle Arrest Functions. Molecular and Cellular Biology. 23(1). 216–228. 172 indexed citations
18.
Wadia, Jehangir S. & Steven F. Dowdy. (2002). Protein transduction technology. Current Opinion in Biotechnology. 13(1). 52–56. 414 indexed citations
19.
Ezhevsky, Sergei A., Alan L. Ho, Michelle Becker‐Hapak, Penny K. Davis, & Steven F. Dowdy. (2001). Differential Regulation of Retinoblastoma Tumor Suppressor Protein by G 1 Cyclin-Dependent Kinase Complexes In Vivo. Molecular and Cellular Biology. 21(14). 4773–4784. 176 indexed citations
20.
Lissy, Natalie A., et al.. (2000). Transduction of Full-Length Tat Fusion Proteins Directly into Mammalian Cells: Analysis of T Cell Receptor Activation-Induced Cell Death. Methods in enzymology on CD-ROM/Methods in enzymology. 322. 508–521. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul A. Khavari Breakdown of academic impact, for papers by David W. Speicher Breakdown of academic impact, for papers by Hartmut Beug Breakdown of academic impact, for papers by Victor Koteliansky Breakdown of academic impact, for papers by Corazon D. Bucana Breakdown of academic impact, for papers by G. Yancey Gillespie Breakdown of academic impact, for papers by Peter F. Johnson Breakdown of academic impact, for papers by Carl Blobel Breakdown of academic impact, for papers by Hanswalter Zentgraf Breakdown of academic impact, for papers by Jer‐Tsong Hsieh
Rankless by CCL
2026